Results 131 to 140 of about 96,425,769 (293)
The Scope 3 emissions of the Greenhouse Gas Protocol are widely recognized globally, and it is important to understand the emissions from an entire value chain and to elucidate the opportunities for their reduction.
Keigo Akimoto +3 more
doaj +1 more source
Metabolic and Fluid Biomarkers Support Microglia Activation in Amyotrophic Lateral Sclerosis
ABSTRACT Amyotrophic lateral sclerosis is an incurable neurodegenerative disease involving motor neuron degeneration and metabolic and immune dysfunction. We combined clinical data, cerebrospinal fluid biomarkers and fluorodeoxyglucose positron emission tomography with magnetic resonance imaging to investigate the role of reactive microglia in disease ...
Matteo Zanovello +10 more
wiley +1 more source
Assessment of Greenhouse Gas Emissions and Mitigation Strategies for a University in Bangladesh
Climate change is an urgent global challenge. Higher education institutions (HEIs) have a crucial role in addressing this issue by reducing their environmental impact.
Mirza Rasheduzzaman +4 more
doaj +1 more source
ABSTRACT Objective Blood biomarkers are increasingly critical for non‐invasive Alzheimer's Disease (AD) diagnostics and research but typically require on‐site processing. Remote point‐of‐care collection methods could enhance biomarker testing in clinical and research settings.
Sara Ho +9 more
wiley +1 more source
Uncovering the carbon cost: Environmental impact of free flap reconstruction procedures in the UK
Introduction: Free flap reconstruction procedures are renowned for their duration and the requirement for many staff and large quantities of equipment.
Benjamin Clay +2 more
doaj +1 more source
Subjective Cognitive Concerns and Cognitive Trajectories in Parkinson's Disease: Biomarker Impact
ABSTRACT Objective To examine the relationship of subjective cognitive concerns (SCC) with biomarkers of Alzheimer's disease (AD), neurodegeneration, and Parkinson's disease (PD) and domain‐specific cognitive trajectories among cognitively unimpaired persons with de novo PD. Method Cognitively unimpaired participants with SCC (n = 294) and without SCC (
Francesca V. Lopez +5 more
wiley +1 more source
Exploring opportunities to reduce scope 3 emissions in renewably powered health services
Exploring opportunities to reduce scope 3 emissions in renewably powered health ...
Mike Forrester (13084887) +4 more
core
Stage‐Specific Patterns of Imaging and Non‐Motor Biomarkers in Spinocerebellar Ataxia Type 3
ABSTRACT Objective Advancements in disease‐modifying therapies for spinocerebellar ataxia Type 3 (SCA3) underscore the need for robust biomarkers to monitor disease progression and evaluate treatment efficacy. Although motor phenotypes have been well characterized, less is known about non‐motor and imaging‐based features across different disease stages.
Chun Li +17 more
wiley +1 more source
Carbon footprint trends and cost-emission dynamics of a Saudi tertiary hospital
Introduction Hospitals are both highly vulnerable to climate change and significant contributors to greenhouse gas (GHG) emissions. In hot-arid regions such as Saudi Arabia, conventional annual carbon footprint assessments often obscure seasonal demand ...
Hamza Alhamza +6 more
doaj +1 more source
A Two‐Stage Plasma Biomarker Algorithm Reduces Amyloid PET Use and the p‐Tau217 Gray Zone
ABSTRACT Objective Plasma p‐Tau217 leaves 30%–50% of patients in an indeterminate “gray zone” often requiring Aβ‐PET. We developed GRAD (Gatekeeper‐Reflex for Alzheimer's Disease), a two‐stage Aβ‐positivity prediction model to improve classification while reserving Aβ‐PET for residual uncertainty.
Harthik Parankusham +7 more
wiley +1 more source

